{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,10,2]],"date-time":"2026-10-02T00:54:05Z","timestamp":1790902445566,"version":"4.1.0"},"reference-count":39,"publisher":"Springer Science and Business Media LLC","issue":"10","license":[{"start":{"date-parts":[[2026,9,4]],"date-time":"2026-09-04T00:00:00Z","timestamp":1788480000000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.springernature.com\/gp\/researchers\/text-and-data-mining"},{"start":{"date-parts":[[2026,9,4]],"date-time":"2026-09-04T00:00:00Z","timestamp":1788480000000},"content-version":"vor","delay-in-days":0,"URL":"https:\/\/www.springernature.com\/gp\/researchers\/text-and-data-mining"}],"content-domain":{"domain":["link.springer.com"],"crossmark-restriction":false},"short-container-title":["Dermatologie"],"published-print":{"date-parts":[[2026,10]]},"DOI":"10.1007\/s00105-026-05780-5","type":"journal-article","created":{"date-parts":[[2026,9,4]],"date-time":"2026-09-04T07:30:38Z","timestamp":1788507038000},"page":"655-660","update-policy":"https:\/\/doi.org\/10.1007\/springer_crossmark_policy","source":"Crossref","is-referenced-by-count":0,"title":["Stellenwert serologischer (Schnell\u2011)Teste zur Fr\u00fcherkennung HPV-bedingter Karzinome","The role of serological (rapid) tests for the early detection of HPV-related cancers"],"prefix":"10.1007","volume":"77","author":[{"given":"Ulrike","family":"Wieland","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Tim","family":"Waterboer","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"297","published-online":{"date-parts":[[2026,9,4]]},"reference":[{"key":"5780_CR1","doi-asserted-by":"publisher","first-page":"536","DOI":"10.1093\/jnci\/djt053","volume":"105","author":"D Anantharaman","year":"2013","unstructured":"Anantharaman\u00a0D, Gheit\u00a0T, Waterboer\u00a0T et\u00a0al (2013) Human papillomavirus infections and upper aero-digestive tract cancers: the ARCAGE study. Journal of the National Cancer Institute 105:536\u2013545","journal-title":"Journal of the National Cancer Institute"},{"key":"5780_CR2","unstructured":"Arroyo LS, Lagheden C, Eklund C et\u00a0al (2025) Chapter 2 - Human Papillomavirus Types. Human Papillomavirus E\u2011Laboratory Manual. https:\/\/www.hpvcenter.se\/wp-content\/uploads\/Chapter-2-Human-Papillomavirus-Types.pdf. Zugegriffen: 9. Aug. 2026"},{"key":"5780_CR3","doi-asserted-by":"publisher","DOI":"10.1080\/21645515.2023.2289242","volume":"19","author":"N Bhatla","year":"2023","unstructured":"Bhatla\u00a0N, Muwonge\u00a0R, Malvi\u00a0SG et\u00a0al (2023) Impact of age at vaccination and cervical HPV infection status on binding and neutralizing antibody titers at 10\u00a0years after receiving single or higher doses of quadrivalent HPV vaccine. Human vaccines & immunotherapeutics 19:2289242","journal-title":"Human vaccines & immunotherapeutics"},{"key":"5780_CR4","doi-asserted-by":"publisher","first-page":"2837","DOI":"10.1007\/s00784-020-03601-0","volume":"25","author":"S Blatt","year":"2021","unstructured":"Blatt\u00a0S, Pabst\u00a0A, Zimmer\u00a0S et\u00a0al (2021) Clinical efficacy of an antibody-based detection system for human papilloma virus infection in oral squamous cell carcinoma. Clinical oral investigations 25:2837\u20132843","journal-title":"Clinical oral investigations"},{"key":"5780_CR5","doi-asserted-by":"publisher","DOI":"10.1016\/j.ebiom.2020.103123","volume":"62","author":"N Brenner","year":"2020","unstructured":"Brenner\u00a0N, Mentzer\u00a0AJ, Hill\u00a0M et\u00a0al (2020) Characterization of human papillomavirus (HPV) 16 E6 seropositive individuals without HPV-associated malignancies after 10\u00a0years of follow-up in the UK Biobank. EBioMedicine 62:103123","journal-title":"EBioMedicine"},{"key":"5780_CR6","doi-asserted-by":"publisher","DOI":"10.1016\/j.eclinm.2022.101659","volume":"53","author":"CJ Busch","year":"2022","unstructured":"Busch\u00a0CJ, Hoffmann\u00a0AS, Viarisio\u00a0D et\u00a0al (2022) Detection of stage I HPV-driven oropharyngeal cancer in asymptomatic individuals in the Hamburg City Health Study using HPV16 E6 serology - A proof-of-concept study. EClinicalMedicine 53:101659","journal-title":"EClinicalMedicine"},{"key":"5780_CR7","first-page":"1025","volume":"23","author":"D Chromy","year":"2025","unstructured":"Chromy\u00a0D, Aigner\u00a0F, Becker\u00a0JC et\u00a0al (2025) German-Austrian guideline on screening for anal dysplasia and anal carcinoma in people living with HIV. Journal der Deutschen Dermatologischen Gesellschaft = Journal of the German Society of Dermatology : JDDG 23:1025\u20131040","journal-title":"Journal der Deutschen Dermatologischen Gesellschaft = Journal of the German Society of Dermatology : JDDG"},{"key":"5780_CR8","doi-asserted-by":"publisher","first-page":"3065","DOI":"10.1093\/annonc\/mdx535","volume":"28","author":"G D\u2019 Souza","year":"2017","unstructured":"D\u2019 Souza\u00a0G, Mcneel\u00a0TS, Fakhry\u00a0C (2017) Understanding personal risk of oropharyngeal cancer: risk-groups for oncogenic oral HPV infection and oropharyngeal cancer. Annals of oncology : official journal of the European Society for Medical Oncology 28:3065\u20133069","journal-title":"Annals of oncology : official journal of the European Society for Medical Oncology"},{"key":"5780_CR9","doi-asserted-by":"publisher","first-page":"1029","DOI":"10.1002\/cncr.33346","volume":"127","author":"VE Drake","year":"2021","unstructured":"Drake\u00a0VE, Fakhry\u00a0C, Windon\u00a0MJ et\u00a0al (2021) Timing, number, and type of sexual partners associated with risk of oropharyngeal cancer. Cancer 127:1029\u20131038","journal-title":"Cancer"},{"key":"5780_CR10","doi-asserted-by":"publisher","first-page":"109","DOI":"10.1016\/j.pvr.2015.06.007","volume":"1","author":"AR Giuliano","year":"2015","unstructured":"Giuliano\u00a0AR, Viscidi\u00a0R, Torres\u00a0BN et\u00a0al (2015) Seroconversion Following Anal and Genital HPV Infection in Men: The HIM Study. Papillomavirus research (Amsterdam, Netherlands) 1:109\u2013115","journal-title":"Papillomavirus research (Amsterdam, Netherlands)"},{"issue":"12","key":"5780_CR11","doi-asserted-by":"publisher","DOI":"10.3390\/cancers13123010","volume":"13","author":"J Hibbert","year":"2021","unstructured":"Hibbert\u00a0J, Halec\u00a0G, Baaken\u00a0D et\u00a0al (2021) Sensitivity and Specificity of Human Papillomavirus (HPV) 16 Early Antigen Serology for HPV-Driven Oropharyngeal Cancer: A Systematic Literature Review and Meta-Analysis. Cancers 13(12):3010","journal-title":"Cancers"},{"key":"5780_CR12","doi-asserted-by":"publisher","first-page":"110","DOI":"10.1158\/1055-9965.EPI-03-0191","volume":"13","author":"GY Ho","year":"2004","unstructured":"Ho\u00a0GY, Studentsov\u00a0YY, Bierman\u00a0R et\u00a0al (2004) Natural history of human papillomavirus type 16 virus-like particle antibodies in young women. Cancer epidemiology, biomarkers & prevention : a publication of the American Association for Cancer Research, cosponsored by the American Society of Preventive Oncology 13:110\u2013116","journal-title":"Cancer epidemiology, biomarkers & prevention : a publication of the American Association for Cancer Research, cosponsored by the American Society of Preventive Oncology"},{"key":"5780_CR13","doi-asserted-by":"publisher","first-page":"2748","DOI":"10.1002\/ijc.30697","volume":"140","author":"D Holzinger","year":"2017","unstructured":"Holzinger\u00a0D, Wichmann\u00a0G, Baboci\u00a0L et\u00a0al (2017) Sensitivity and specificity of antibodies against HPV16 E6 and other early proteins for the detection of HPV16-driven oropharyngeal squamous cell carcinoma. International journal of cancer 140:2748\u20132757","journal-title":"International journal of cancer"},{"key":"5780_CR14","doi-asserted-by":"publisher","first-page":"1335","DOI":"10.1093\/annonc\/mdz138","volume":"30","author":"AR Kreimer","year":"2019","unstructured":"Kreimer\u00a0AR, Ferreiro-Iglesias\u00a0A, Nygard\u00a0M et\u00a0al (2019) Timing of HPV16-E6 antibody seroconversion before OPSCC: findings from the HPVC3 consortium. Annals of oncology : official journal of the European Society for Medical Oncology 30:1335\u20131343","journal-title":"Annals of oncology : official journal of the European Society for Medical Oncology"},{"key":"5780_CR15","doi-asserted-by":"publisher","first-page":"2708","DOI":"10.1200\/JCO.2012.47.2738","volume":"31","author":"AR Kreimer","year":"2013","unstructured":"Kreimer\u00a0AR, Johansson\u00a0M, Waterboer\u00a0T et\u00a0al (2013) Evaluation of human papillomavirus antibodies and risk of subsequent head and neck cancer. Journal of clinical oncology : official journal of the American Society of Clinical Oncology 31:2708\u20132715","journal-title":"Journal of clinical oncology : official journal of the American Society of Clinical Oncology"},{"key":"5780_CR16","doi-asserted-by":"publisher","DOI":"10.1093\/jnci\/djx005","volume":"109","author":"AR Kreimer","year":"2017","unstructured":"Kreimer\u00a0AR, Johansson\u00a0M, Yanik\u00a0EL et\u00a0al (2017) Kinetics of the Human Papillomavirus Type 16 E6 Antibody Response Prior to Oropharyngeal Cancer. Journal of the National Cancer Institute 109:djx005","journal-title":"Journal of the National Cancer Institute"},{"key":"5780_CR17","doi-asserted-by":"publisher","first-page":"1859","DOI":"10.1002\/cncr.31256","volume":"124","author":"AR Kreimer","year":"2018","unstructured":"Kreimer\u00a0AR, Shiels\u00a0MS, Fakhry\u00a0C et\u00a0al (2018) Screening for human papillomavirus-driven oropharyngeal cancer: Considerations for feasibility and strategies for research. Cancer 124:1859\u20131866","journal-title":"Cancer"},{"key":"5780_CR18","doi-asserted-by":"publisher","DOI":"10.1177\/10732748261462289","volume":"33","author":"KaL Kuhs","year":"2026","unstructured":"Kuhs\u00a0KaL, Otieno\u00a0C, Sudenga\u00a0S et\u00a0al (2026) The Association Between Human Papillomavirus Type 16 E6 Seroprevalence and Degrees of Anal Disease Among Men With HIV: A Nested Case Control Study. Cancer control : journal of the Moffitt Cancer Center 33:10732748261462289","journal-title":"Cancer control : journal of the Moffitt Cancer Center"},{"key":"5780_CR19","doi-asserted-by":"publisher","DOI":"10.1016\/j.ebiom.2025.106057","volume":"123","author":"JMA Kusters","year":"2026","unstructured":"Kusters\u00a0JMA, Brenner\u00a0N, Bogaards\u00a0JA et\u00a0al (2026) Evaluation of an HPV16-L1 antibody rapid test for oropharyngeal cancer diagnosis: diagnostic accuracy and challenges in real-world settings. EBioMedicine 123:106057","journal-title":"EBioMedicine"},{"key":"5780_CR20","doi-asserted-by":"publisher","first-page":"389","DOI":"10.1002\/ijc.34710","volume":"154","author":"JMA Kusters","year":"2024","unstructured":"Kusters\u00a0JMA, Diergaarde\u00a0B, Ness\u00a0A et\u00a0al (2024) Diagnostic accuracy of HPV16 early antigen serology for HPV-driven oropharyngeal cancer is independent of age and sex. International journal of cancer 154:389\u2013402","journal-title":"International journal of cancer"},{"key":"5780_CR21","doi-asserted-by":"publisher","first-page":"683","DOI":"10.1158\/1055-9965.EPI-14-1217","volume":"24","author":"L Kuhs","year":"2015","unstructured":"Kuhs\u00a0L, Anantharaman\u00a0KA, Waterboer\u00a0D, et\u00a0al\u00a0T (2015) Human Papillomavirus 16 E6 Antibodies in Individuals without Diagnosed Cancer: A\u00a0Pooled Analysis. Cancer epidemiology, biomarkers & prevention : a\u00a0publication of the American Association for Cancer Research, cosponsored by the American Society of Preventive Oncology 24:683\u2013689","journal-title":"Cancer epidemiology, biomarkers & prevention : a\u00a0publication of the American Association for Cancer Research, cosponsored by the American Society of Preventive Oncology"},{"key":"5780_CR22","doi-asserted-by":"publisher","first-page":"46","DOI":"10.1016\/j.canep.2016.03.003","volume":"42","author":"KA Lang Kuhs","year":"2016","unstructured":"Lang Kuhs\u00a0KA, Pawlita\u00a0M, Gibson\u00a0SP et\u00a0al (2016) Characterization of human papillomavirus antibodies in individuals with head and neck cancer. Cancer epidemiology 42:46\u201352","journal-title":"Cancer epidemiology"},{"key":"5780_CR23","doi-asserted-by":"publisher","first-page":"2658","DOI":"10.1002\/cncr.32799","volume":"126","author":"KA Lang Kuhs","year":"2020","unstructured":"Lang Kuhs\u00a0KA, Wood\u00a0CB, Wiggleton\u00a0J et\u00a0al (2020) Transcervical sonography and human papillomavirus 16 E6 antibodies are sensitive for the detection of oropharyngeal cancer. Cancer 126:2658\u20132665","journal-title":"Cancer"},{"key":"5780_CR24","doi-asserted-by":"publisher","first-page":"306","DOI":"10.1038\/s41571-022-00603-7","volume":"19","author":"M Lechner","year":"2022","unstructured":"Lechner\u00a0M, Liu\u00a0J, Masterson\u00a0L et\u00a0al (2022) HPV-associated oropharyngeal cancer: epidemiology, molecular biology and clinical management. Nature reviews. Clinical oncology 19:306\u2013327","journal-title":"Nature reviews. Clinical oncology"},{"key":"5780_CR25","doi-asserted-by":"publisher","DOI":"10.1371\/journal.pone.0203403","volume":"13","author":"BA Leconte","year":"2018","unstructured":"Leconte\u00a0BA, Szaniszlo\u00a0P, Fennewald\u00a0SM et\u00a0al (2018) Differences in the viral genome between HPV-positive cervical and oropharyngeal cancer. PloS one 13:e0203403","journal-title":"PloS one"},{"key":"5780_CR26","doi-asserted-by":"publisher","first-page":"198","DOI":"10.1016\/S1473-3099(17)30653-9","volume":"18","author":"C Lin","year":"2018","unstructured":"Lin\u00a0C, Franceschi\u00a0S, Clifford\u00a0GM (2018) Human papillomavirus types from infection to cancer in the anus, according to sex and HIV status: a\u00a0systematic review and meta-analysis. The Lancet. Infectious diseases 18:198\u2013206","journal-title":"The Lancet. Infectious diseases"},{"key":"5780_CR27","first-page":"3","volume":"83","author":"AD Loenenbach","year":"2019","unstructured":"Loenenbach\u00a0AD, Poethko-M\u00fcller\u00a0C, Pawlita\u00a0M et\u00a0al (2019) Mucosal and cutaneous Human Papillomavirus seroprevalence among adults in the prevaccine era in Germany - Results from a nationwide population-based survey. International journal of infectious diseases : IJID : official publication of the International Society for Infectious Diseases 83:3\u201311","journal-title":"International journal of infectious diseases : IJID : official publication of the International Society for Infectious Diseases"},{"issue":"1","key":"5780_CR28","doi-asserted-by":"publisher","DOI":"10.1038\/s41541-020-0165-x","volume":"5","author":"FC Mariz","year":"2020","unstructured":"Mariz\u00a0FC, Bender\u00a0N, Anantharaman\u00a0D et\u00a0al (2020) Peak neutralizing and cross-neutralizing antibody levels to human papillomavirus types 6\/16\/18\/31\/33\/45\/52\/58 induced by bivalent and quadrivalent HPV vaccines. NPJ vaccines 5(1):14","journal-title":"NPJ vaccines"},{"key":"5780_CR29","doi-asserted-by":"publisher","DOI":"10.1371\/journal.ppat.1000091","volume":"4","author":"KM Michael","year":"2008","unstructured":"Michael\u00a0KM, Waterboer\u00a0T, Sehr\u00a0P et\u00a0al (2008) Seroprevalence of 34 human papillomavirus types in the German general population. PLoS pathogens 4:e1000091","journal-title":"PLoS pathogens"},{"key":"5780_CR30","doi-asserted-by":"publisher","first-page":"1908","DOI":"10.1002\/cam4.2039","volume":"8","author":"M Reuschenbach","year":"2019","unstructured":"Reuschenbach\u00a0M, Tinhofer\u00a0I, Wittekindt\u00a0C et\u00a0al (2019) A systematic review of the HPV-attributable fraction of oropharyngeal squamous cell carcinomas in Germany. Cancer medicine 8:1908\u20131918","journal-title":"Cancer medicine"},{"key":"5780_CR31","doi-asserted-by":"publisher","first-page":"3613","DOI":"10.1200\/JCO.21.01785","volume":"40","author":"HA Robbins","year":"2022","unstructured":"Robbins\u00a0HA, Ferreiro-Iglesias\u00a0A, Waterboer\u00a0T et\u00a0al (2022) Absolute Risk of Oropharyngeal Cancer After an HPV16-E6 Serology Test and Potential Implications for Screening: Results From the Human Papillomavirus Cancer Cohort Consortium. Journal of clinical oncology : official journal of the American Society of Clinical Oncology 40:3613\u20133622","journal-title":"Journal of clinical oncology : official journal of the American Society of Clinical Oncology"},{"key":"5780_CR32","doi-asserted-by":"publisher","first-page":"4768","DOI":"10.1016\/j.vaccine.2017.12.079","volume":"36","author":"J Schiller","year":"2018","unstructured":"Schiller\u00a0J, Lowy\u00a0D (2018) Explanations for the high potency of HPV prophylactic vaccines. Vaccine 36:4768\u20134773","journal-title":"Vaccine"},{"key":"5780_CR33","doi-asserted-by":"crossref","unstructured":"Schiller JT, Kines RC, Day PM et\u00a0al. (2026) Exceeding expectations: factors contributing to the potency of human papillomavirus vaccines. The Lancet. Microbe:101401","DOI":"10.1016\/j.lanmic.2026.101401"},{"key":"5780_CR34","doi-asserted-by":"publisher","first-page":"261","DOI":"10.1111\/jop.70075","volume":"55","author":"CS Schouten","year":"2026","unstructured":"Schouten\u00a0CS, Guarda\u00a0V, Stadler\u00a0TM et\u00a0al (2026) Diagnostic Performance of the PrevoCheck for the Detection of Human Papillomavirus 16-Driven Head and Neck Squamous Cell Carcinoma. Journal of oral pathology & medicine : official publication of the International Association of Oral Pathologists and the American Academy of Oral Pathology 55:261\u2013266","journal-title":"Journal of oral pathology & medicine : official publication of the International Association of Oral Pathologists and the American Academy of Oral Pathology"},{"key":"5780_CR35","doi-asserted-by":"publisher","first-page":"1694","DOI":"10.1002\/ijc.34850","volume":"154","author":"EA Stier","year":"2024","unstructured":"Stier\u00a0EA, Clarke\u00a0MA, Deshmukh\u00a0AA et\u00a0al (2024) International Anal Neoplasia Society\u2019s consensus guidelines for anal cancer screening. International journal of cancer 154:1694\u20131702","journal-title":"International journal of cancer"},{"key":"5780_CR36","doi-asserted-by":"publisher","DOI":"10.1016\/j.ebiom.2020.103143","volume":"62","author":"T Waterboer","year":"2020","unstructured":"Waterboer\u00a0T, Brenner\u00a0N, Klussmann\u00a0JP et\u00a0al (2020) Study results and related evidence do not support use of HPV16 L1 DRH1 antibodies as a cancer screening test. EBioMedicine 62:103143","journal-title":"EBioMedicine"},{"key":"5780_CR37","doi-asserted-by":"publisher","first-page":"435","DOI":"10.1016\/S0140-6736(24)01097-3","volume":"404","author":"F Wei","year":"2024","unstructured":"Wei\u00a0F, Georges\u00a0D, Man\u00a0I et\u00a0al (2024) Causal attribution of human papillomavirus genotypes to invasive cervical cancer worldwide: a systematic analysis of the global literature. Lancet (London, England) 404:435\u2013444","journal-title":"Lancet (London, England)"},{"key":"5780_CR38","doi-asserted-by":"publisher","DOI":"10.1016\/j.ebiom.2020.102804","volume":"56","author":"T Weiland","year":"2020","unstructured":"Weiland\u00a0T, Eckert\u00a0A, Tomazic\u00a0PV et\u00a0al (2020) DRH1 - a novel blood-based HPV tumour marker. EBioMedicine 56:102804","journal-title":"EBioMedicine"},{"key":"5780_CR39","unstructured":"Who (2026) WHO guideline for screening and treatment of cervical pre-cancer lesions for cervical cancer prevention: Use of human papillomavirus (HPV) DNA genotyping. https:\/\/www.who.int\/publications\/i\/item\/9789240121744. Zugegriffen: 9. Aug. 2026"}],"container-title":["Die Dermatologie"],"original-title":[],"language":"de","link":[{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1007\/s00105-026-05780-5.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/article\/10.1007\/s00105-026-05780-5","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1007\/s00105-026-05780-5.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2026,10,2]],"date-time":"2026-10-02T00:04:25Z","timestamp":1790899465000},"score":1,"resource":{"primary":{"URL":"https:\/\/link.springer.com\/10.1007\/s00105-026-05780-5"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2026,9,4]]},"references-count":39,"journal-issue":{"issue":"10","published-print":{"date-parts":[[2026,10]]}},"alternative-id":["5780"],"URL":"https:\/\/doi.org\/10.1007\/s00105-026-05780-5","relation":{},"ISSN":["2731-7005","2731-7013"],"issn-type":[{"value":"2731-7005","type":"print"},{"value":"2731-7013","type":"electronic"}],"subject":[],"published":{"date-parts":[[2026,9,4]]},"assertion":[{"value":"25 August 2026","order":1,"name":"received","label":"Received","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"25 August 2026","order":2,"name":"accepted","label":"Accepted","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"4 September 2026","order":3,"name":"first_online","label":"First Online","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"T.\u00a0Waterboer ist Mitglied in Steering Committees von durch MSD Sharp & Dohme (Merck Inc.) finanzierten Studien. Diese Studien befassen sich mit Impfpr\u00e4vention von HPV-getriebenen Kopf- und Halstumoren, nicht aber mit deren Screening und Fr\u00fcherkennung, und insbesondere auch nicht HPV-16-E6-Serologie. U.\u00a0Wieland gibt an, dass kein Interessenkonflikt besteht.","order":1,"name":"Ethics","label":"Interessenkonflikt","group":{"name":"EthicsHeading","label":"Einhaltung ethischer Richtlinien"}},{"value":"F\u00fcr diesen Beitrag wurden von den Autor\/-innen keine Studien an Menschen oder Tieren durchgef\u00fchrt. F\u00fcr die aufgef\u00fchrten Studien gelten die jeweils dort angegebenen ethischen Richtlinien.","order":2,"name":"Ethics","group":{"name":"EthicsHeading","label":"Einhaltung ethischer Richtlinien"}}]}}